The Group B Streptococcal β and Pneumococcal Hic Proteins Are Structurally Related Immune Evasion Molecules That Bind the Complement Inhibitor Factor H in an Analogous Fashion 1
暂无分享,去创建一个
S. Meri | P. Zipfel | H. Jarva | T. Jokiranta | J. Hellwage | M. Lehtinen
[1] L. Bevanger. Ibc proteins as serotype markers of group B streptococci. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.
[2] S. Meri,et al. Complement resistance mechanisms of streptococci. , 2003, Molecular immunology.
[3] G. Lindahl,et al. A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface , 2002, Journal of bacteriology.
[4] K. Boyer,et al. Group B streptococcal infections. , 2002, Pediatrics in review.
[5] U. H. Stroeher,et al. The Human Complement Regulator Factor H Binds Pneumococcal Surface Protein PspC via Short Consensus Repeats 13 to 15 , 2002, Infection and Immunity.
[6] G. Lindahl,et al. Streptococcal β Protein Has Separate Binding Sites for Human Factor H and IgA-Fc* , 2002, The Journal of Biological Chemistry.
[7] L. Björck,et al. Streptococcus pneumoniae Evades Complement Attack and Opsonophagocytosis by Expressing the pspC Locus-Encoded Hic Protein That Binds to Short Consensus Repeats 8–11 of Factor H1 , 2002, The Journal of Immunology.
[8] L. McDaniel,et al. PspC, a Pneumococcal Surface Protein, Binds Human Factor H , 2001, Infection and Immunity.
[9] L. Björck,et al. Hic, a Novel Surface Protein of Streptococcus pneumoniae That Interferes with Complement Function* , 2000, The Journal of Biological Chemistry.
[10] S. Meri,et al. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. , 2000, The Journal of biological chemistry.
[11] D. Pérez-Caballero,et al. Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high‐affinity group A Streptococcus binding site in FHL‐1 , 2000, European journal of immunology.
[12] G. Lindahl,et al. Group B Streptococcal Surface Proteins as Targets for Protective Antibodies: Identification of Two Novel Proteins in Strains of Serotype V , 1999, Infection and Immunity.
[13] S. Meri,et al. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. , 1999, Journal of immunology.
[14] S. Meri,et al. Complement-resistance mechanisms of bacteria. , 1999, Microbes and infection.
[15] A. Schuchat. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.
[16] P. Zipfel,et al. Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.
[17] V. Fischetti,et al. M Protein of the Group A StreptococcusBinds to the Seventh Short Consensus Repeat of Human Complement Factor H , 1998, Infection and Immunity.
[18] P. Zipfel,et al. The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins. , 1998, The Biochemical journal.
[19] P. Coll,et al. Group B streptococcal meningitis in adults: report of twelve cases and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] S. Hammerschmidt,et al. SpsA, a novel pneumococcal surface protein with specific binding to secretory Immunoglobulin A and secretory component , 1997, Molecular microbiology.
[21] D. Lublin,et al. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.
[22] P. Zipfel,et al. Mapping of the domains required for decay acceleration activity of the human factor H‐like protein 1 and factor H , 1996, European journal of immunology.
[23] M. Pangburn,et al. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Lindahl,et al. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha , 1996, Infection and immunity.
[25] P. Zipfel,et al. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. , 1995, Journal of immunology.
[26] P. Zipfel,et al. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. , 1995, Gene.
[27] D. Lublin,et al. Identification of complement regulatory domains in human factor H. , 1995, Journal of immunology.
[28] G. Lindahl,et al. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.
[29] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[30] S. Meri,et al. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. , 1994, Biochemical and biophysical research communications.
[31] A. Schuchat,et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.
[32] G. Lindahl,et al. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections , 1993, The Journal of experimental medicine.
[33] S. Meri,et al. Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.
[34] G. Lindahl,et al. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline‐rich region with unique structure and isolation of N‐terminal fragments with IgA‐binding capacity , 1991, European journal of immunology.
[35] G. Lindahl,et al. Characterization of an IgA receptor from group B streptococci: specificity for serum IgA , 1990, European journal of immunology.
[36] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[37] Eugene W. Myers,et al. Basic local alignment search tool. Journal of Molecular Biology , 1990 .
[38] V. Fischetti,et al. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Gotschlich,et al. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen , 1984, The Journal of experimental medicine.
[40] Dwight R. Johnson,et al. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes , 1984, Journal of clinical microbiology.
[41] J. Sykes,et al. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α, 6α-diphenyl glycoluril (Iodogen) , 1981 .
[42] S. Barbero,et al. [Infectious diseases in the fetus and newborn infant]. , 1977, Archivio per le scienze mediche.
[43] C. P. Kenny,et al. Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance Spectroscopy , 1977 .
[44] D. Kasper,et al. Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus , 1976, The Journal of experimental medicine.
[45] D. Kasper,et al. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. , 1973, Journal of immunology.
[46] K. Nicholas,et al. GeneDoc: Analysis and visualization of genetic variation , 1997 .
[47] J. Sykes,et al. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). , 1981, Analytical biochemistry.